NetraMark Holdings Company Description

NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide.

It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations.

The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023.

NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.

NetraMark Holdings Inc.

Country	Canada
Founded	2016
Industry	Health Information Services
Sector	Healthcare
CEO	George Achilleos

Contact Details

Address: 1655 Dupont Street Toronto, ON M6P 3T1 Canada
Phone	403 681 2549
Website	netramark.com

Stock Details

Ticker Symbol	AIAI
Exchange	Canadian Securities Exchange
Fiscal Year	October - September
Reporting Currency	CAD
SIC Code	2834

Key Executives

Name	Position
George Achilleos	President, Chief Executive Officer and Director
Dr. Joseph Geraci Ph.D.	Founder, Chief Scientific and Technical Officer and Director
Swapan Kakumanu ACA, ACWA, CGA	Chief Financial Officer and Corporate Secretary
Josh Spiegel	President of NetraMark Corp
Jaime Hackett	Vice President of Marketing
Dr. Luca Pani M.D.	Chief Innovation and Regulatory Officer and Chief Medical Advisor
Dr. Kaveh Kavoosi	Head of Progressive Medicine
Dr. Larry Alphs	Chief Medical Officer and Member of Advisory Board
Dr. Angelico Carta M.D.	Chief Strategy Officer
Dr. Jan Sedway Ph.D.	Senior Vice President of Clinical Science